Cyclin dependent kinase 4/6 (CDK4/6) inhibitors, in combination with MAPK inhibitors, induced senescence in lung and pancreatic cancer mouse models, and the SASP contributed to a potent antitumor immune response68,69. The gene discussed is CDK4; the disease is pancreatic neoplasm.